Sara SharghiLavan

Mrs. Sara SharghiLavan

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2025 in Sensors
Verified
Journal Article
Open access
PDF file
AMAlexandra Stefania Mihai
Alexandra Stefania Mihai
AMAlexandra Stefania Mihai
Alexandra Stefania Mihai
Oana GEMANOana GEMAN
Oana GEMAN
RTRoxana Toderean
Roxana Toderean
LMLucas Miron
Lucas Miron
SSSara SharghiLavan
Sara SharghiLavan
Electroencephalography (EEG) remains an essential method for monitoring brain activity, but the limitations of conventional systems due to the complexity of installation and lack of portability have led to the introduction and development of in-ear EEG technology. In-ear EEG is an emerging method of recording electrical activity in the brain and is an innovative concept that offers multiple advantages both from the point of view of the device itself, which is easily portable, and from the user’s point of view, who is more comfortable with it, even in long-term use. One of the fundamental components of this type of device is the electrodes used to capture the EEG signal. This innovative method allows bioelectrical signals to be captured through electrodes integrated into an earpiece, offering significant advantages in terms of comfort, portability, and accessibility. Recent studies have demonstrated that in-ear EEG can record signals qualitatively comparable to scalp EEG, with an optimized signal-to-noise ratio and improved electrode stability. Furthermore, this review provides a comparative synthesis of performance parameters such as signal-to-noise ratio (SNR), common-mode rejection ratio (CMRR), signal amplitude, and comfort, highlighting the strengths and limitations of in-ear EEG systems relative to conventional scalp EEG. This study also introduces a visual model outlining the stages of technological development for in-ear EEG, from initial research to clinical and commercial deployment. Particular attention is given to current innovations in electrode materials and design strategies aimed at balancing biocompatibility, signal fidelity, and anatomical adaptability. This article analyzes the evolution of EEG in the ear, briefly presents the comparative aspects of EEG—EEG in the ear from the perspective of the electrodes used, highlighting the advantages and challenges of using this new technology. It also discusses aspects related to the electrodes used in EEG in the ear: types of electrodes used in EEG in the ear, improvement of contact impedance, and adaptability to the anatomical variability of the ear canal. A comparative analysis of electrode performance in terms of signal quality, long-term stability, and compatibility with use in daily life was also performed. The integration of intra-auricular EEG in wearable devices opens new perspectives for clinical applications, including sleep monitoring, epilepsy diagnosis, and brain–computer interfaces. This study highlights the challenges and prospects in the development of in-ear EEG electrodes, with a focus on integration into wearable devices and the use of biocompatible materials to improve durability and enhance user comfort. Despite its considerable potential, the widespread deployment of in-ear EEG faces challenges such as anatomical variability of the ear canal, optimization of ergonomics, and reduction in motion artifacts. Future research aims to improve device design for long-term monitoring, integrate advanced signal processing algorithms, and explore applications in neurorehabilitation and early diagnosis of neurodegenerative diseases.

8 August 2025 in bioRxiv
Verified
Preprint
Open access
SSSara SharghiLavan
Sara SharghiLavan
LFLeila Mehdizadeh Fanid
Leila Mehdizadeh Fanid
OGOana Geman
Oana Geman
HSHassan Shahrokhi
Hassan Shahrokhi
HSHadi Seyedarabi
Hadi Seyedarabi
Background: Individuals with Autism Spectrum Disorder (ASD) show atypical auditory perception. The N100 event-related potential (ERP) reflects early auditory encoding, predictive coding, and sensory gain. Therefore, this study examined N100 responses to speech stimuli as a neural marker of auditory processing differences in ASD. Methods: Event-related potentials (ERPs) were recorded using OpenBCI in 12 boys diagnosed with Level 1 ASD (requiring minimal support) and 15 typically developing (TD) peers. Participants passively listened to Romanian sentences systematically varied in pitch (normal, high, low), distance-based intensity (0.5, 1, 2 meters; 65, 59, 53 dB), and spatial presentation (binaural, left, right). N100 amplitudes and latencies were analyzed using Python and SPSS. Results: ASD group indicated significantly reduced N100 amplitudes for normal-pitch stimuli ( p = .030, η² = .175) and binaural presentation ( p = .030, η² = .175). Marginal reductions were also observed for low pitch ( p = .096, η² = .120), speech presented from a 0.5-meter distance ( p = .058, η² = .147), and unilateral conditions ( p s = .066–.077, η²s = .130–.142). No group differences emerged for N100 latency. These findings suggest attenuated early auditory responses in ASD to both typical and spatially complex speech cues. Conclusions: Results support predictive coding models proposing reduced sensory precision in ASD. The consistent amplitude attenuation, including near-significant findings, points to subtle but pervasive impairments in early auditory encoding. The use of ecologically valid speech stimuli and portable EEG underscores the translational potential of N100 as a biomarker for early identification and intervention in autism.

14 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ANAzadeh Sharifi Nowghabi
Azadeh Sharifi Nowghabi
SSSara SharghiLavan
Sara SharghiLavan
ABAbdolali Bagheri
Abdolali Bagheri
MIMorteza Izadifar
Morteza Izadifar
Wayfinding in hospitals is often hindered by ineffective signage; however, the cognitive mechanisms of healthcare wayfinding symbols comprehension remain under-researched. This study utilized eye-tracking and spatial gaze mapping to examine how visual complexity, abstraction, and human figuration modulate perception in 40 healthy adults viewing 24 hospital-related healthcare wayfinding symbols. Results indicate that pupil size is a sensitive physiological marker of cognitive load, significantly influenced by visual complexity ( χ 2 = 11.32, p = .022) and abstraction ( χ 2 = 7.49, p = .027). Human figuration reduced fixation duration and increased saccade amplitude, facilitating efficient semantic integration. Furthermore, human-centric healthcare wayfinding symbols elicited streamlined gaze trajectories, whereas abstract/complex designs induced chaotic scanpaths. These findings suggest that human figuration acts as a cognitive scaffold, reducing mental effort. We provide evidence-based guidelines for optimizing healthcare wayfinding symbols by prioritizing human body representations and balancing abstraction levels. Highlight: Pupil size indexes cognitive load during symbol comprehension. Human figuration cuts fixation duration, boosting wayfinding efficiency. Abstract symbols increase pupil dilation, raising cognitive load.

16 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
Oana GEMANOana GEMAN
Oana GEMAN
SSSara SharghiLavan
Sara SharghiLavan
HAHadi Abbasi
Hadi Abbasi
RTRoxana Toderean
Roxana Toderean
Octavian Adrian PostolacheOctavian Adrian Postolache
Octavian Adrian Postolache
MKMatti Karppa
Matti Karppa
The main challenges in the life of a child with autism are difficulties in communication, behavior, and social interaction. Early diagnosis of this neurodevelopmental disorder improves patient outcomes by enabling more effective, personalized interventions. This diagnosis can sometimes be difficult, especially in very young children. Non-invasive, relatively accessible, and able to reflect neural function in real time, electroencephalography (EEG) shows promise in the detection of Autism spectrum disorders (ASD). However, because EEG data is still difficult for experts to understand, machine learning and artificial intelligence (AI) are beginning to be used in this field as well. In this paper, a ResNet+BiLSTM hybrid deep network was applied and achieved high accuracy in distinguishing individuals with autism from neurotypical subjects. Since AI models typically provide predictions without clear explanations, this study employs explainable AI (XAI) methods such as SHAP (SHapley Additive exPlanations) and LIME (Local Interpretable Model-agnostic Explanations) to clarify their decision-making.Delta, theta, alpha, beta, and gamma waves, as well as ERP components P100, N100, P200, MMN, and P600, were analyzed in the two neurotypical and autistic groups that were compared in this study using EEG recordings. By integrating SHAP and LIME, the system achieved both accurate classification and transparent explanations, pointing to EEG- and ERP-based features as reliable biomarkers for ASD.